Table 1 Procedural parameters for the 10 patients who underwent various embolisation procedures using the triaxial system
Procedure | Embolic used | Procedure time (min) | Contrast media usage (ml) | Fluoroscopy time (min) | DAP (Gy.cm2) | Reference Fluoroscopy time (min) | Reference DAP (Gy.cm2) | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Mean | Min | Max | Mean | Min | Max | ||||||
BAE | PVA (250 – 355 microns) | 129 | 140 | 16.3 | 84.79 | 25.7 | 10.9 | 46.5 | 138.20 | 72.20 | 314.53 |
Endoleak embolisation (intercoastal artery) | NBCA glue with Lipiodol (1:3 ratio) and detachable coils | 160 | 55 | 35.5 | 190.56 | 29.8 | 14.3 | 44.5 | 140.97 | 109.72 | 302.54 |
Endoleak embolisation (Iliolumbar artery) | NBCA glue with Lipiodol (1:3 ratio) | 182 | 125 | 39.6 | 286.41 | 29.8 | 14.3 | 44.5 | 140.97 | 109.72 | 302.54 |
PAE | Embosphere microspheres (100–300 microns) | 130 | 75 | 19.5 | 224.58 | 30.9 | 15.5 | 48.3 | 450.70 | 248.30 | 791.73 |
TACE | Doxorubicin- Lipiodol emulsion (1:2 ratio) | 134 | 140 | 14.0 | 171.36 | 14.8 | 2.7 | 48.7 | 270.12 | 20.46 | 615.74 |
TACE | Doxorubicin- Lipiodol emulsion (1:2 ratio) | 165 | 95 | 18.6 | 213.10 | 14.8 | 2.7 | 48.7 | 270.12 | 20.46 | 615.74 |
TACE | Doxorubicin- Lipiodol emulsion (1:2 ratio) | 109 | 50 | 22.3 | 239.02 | 14.8 | 2.7 | 48.7 | 270.12 | 20.46 | 615.74 |
TACE | Doxorubicin- Lipiodol emulsion (1:2 ratio) | 198 | 76 | 28.0 | 281.67 | 14.8 | 2.7 | 48.7 | 270.12 | 20.46 | 615.74 |
MAAa | Macro-Agglutinated Albumin Technetium 99 m | 138 | 87 | 10.6 | 121.11 | 14.8 | 2.7 | 48.7 | 270.12 | 20.46 | 615.74 |
Y-90a | Resin microspheres (SIRTex) | 192 | 95 | 25.6 | 271.45 | 14.8 | 2.7 | 48.7 | 270.12 | 20.46 | 615.74 |